← Back to All Filings

Paul J. Diaz Reports Initial Beneficial Ownership in Merck & Co., Inc. (MRK)

Low SignificanceNovember 3, 2026 at 3:13:06 PM EST

Merck & Co., Inc.

$MRK3CIK: 0000310158

Subscribe to track MRK

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Merck & Co., Inc. (NYSE: MRK) - Form 3 Initial Statement

Insider: Paul J. Diaz Role: Director Effective Date: November 1, 2026 Filing Date: November 3, 2026

Holdings Reported: • Direct: 200 Common Shares • Indirect (Revocable Trust): 96 Common Shares • Total Beneficial Ownership: 296 Common Shares

Significance: Low (Routine Initial Ownership Disclosure)

Comprehensive Analysis

Overview

On November 3, 2026, Paul J. Diaz filed an initial statement of beneficial ownership of securities (Form 3) with the SEC regarding Merck & Co., Inc. (MRK). The event date requiring the filing was November 1, 2026, marking his appointment as a member of the Board of Directors.

Reported Holdings

Mr. Diaz reported beneficial ownership totaling 296 shares of Merck & Co., Inc. Common Stock, categorized as follows:

  • Direct Ownership: 200 shares held directly.
  • Indirect Ownership: 96 shares held via the Reporting Person's Revocable Trust.

No derivative securities or options were reported in Table II.

Market and Trading Significance

This Form 3 filing represents a routine disclosure following Mr. Diaz's appointment to the Board of Directors. It reports existing baseline equity holdings rather than an open-market transaction. Given the modest size of the position (296 shares), this disclosure does not indicate immediate directional sentiment and is classified as Low trading significance.

Topics:#Merck#MRK#Form3#InsiderOwnership#Pharma

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.